Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC

by Narek Shaverdian, MD, Michael Offin, MD, Annemarie F. Shepherd, MD, Matthew D. Hellmann, MD, Daniel R. Gomez, MD, Jamie E. Chaft, MD, Andreas Rimner, MD
Published 2021-07-01

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

by Narek Shaverdian, Maria Thor, Annemarie F. Shepherd, Michael D. Offin, Andrew Jackson, Abraham J. Wu, Daphna Y. Gelblum, Ellen D. Yorke, Charles B. Simone II, Jamie E. Chaft, Matthew D. Hellmann, Daniel R. Gomez, Andreas Rimner, Joseph O. Deasy
Published 2020-07-01

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer

by Leo Y. Luo, MD, Robert M. Samstein, MD, PhD, Rosalind Dick-Godfrey, Baho Sidiqi, Chunyu Wang, Federica Oro, Mark Sonnick, MD, Paul K. Paik, MD, Jamie E. Chaft, MD, Narek Shaverdian, MD, Daniel R. Gomez, MD, Andreas Rimner, MD, Abraham J. Wu, MD
Published 2021-01-01

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition

by Donata von Reibnitz, BS, Jamie E. Chaft, MD, Abraham J. Wu, MD, Robert Samstein, MD, PhD, Matthew D. Hellmann, MD, Andrew J. Plodkowski, MD, Zhigang Zhang, PhD, Weiji Shi, MS, Rosalind Dick-Godfrey, BS, Kelly H. Panchoo, BA, Christopher A. Barker, MD, Andreas Rimner, MD
Published 2018-07-01

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

by David Jones, Taha Merghoub, Hok Yee Chan, Franco Verde, Daphne Wang, James R White, Tricia R Cottrell, Joshua E Reuss, Stephen Broderick, Kellie N Smith, Marianna Zahurak, Mara Lanis, Joseph C Murray, Caroline McCarthy, Stephen Yang, Richard Battafarano, Errol Bush, Malcolm Brock, Jinny Ha, Janis Taube, Peter Illei, Ben Levy, Jamie E Chaft
Published 2020-07-01

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC

by Annemarie F. Shepherd, MD, Anthony F. Yu, MD, Michelle Iocolano, MD, Jonathan E. Leeman, MD, Aaron T. Wild, MD, Brandon S. Imber, MD, MA, Jamie E. Chaft, MD, Michael Offin, MD, James Huang, MD, James M. Isbell, MD, MSCI, Abraham J. Wu, MD, Daphna Y. Gelblum, MD, Narek Shaverdian, MD, Charles B. Simone, II, MD, Daniel Gomez, MD, Ellen Yorke, PhD, Andrew Jackson, PhD, Andreas Rimner, MD
Published 2021-08-01

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers

by Noura J. Choudhury, MD, Jaime L. Schneider, MD, PhD, Tejas Patil, MD, Viola W. Zhu, MD, PhD, Debra A. Goldman, MS, Soo-Ryum Yang, MD, Christina J. Falcon, MPH, Andrew Do, BS, Yunan Nie, MD, Andrew J. Plodkowski, MD, Jamie E. Chaft, MD, Subba R. Digumarthy, MD, Natasha Rekhtman, MD, PhD, Maria E. Arcila, MD, Alexia Iasonos, PhD, Sai-Hong I. Ou, MD, PhD, Jessica J. Lin, MD, Alexander Drilon, MD
Published 2021-07-01